Key result
Mesalamine withdrawal and corticosteroids rapidly resolve drug-induced myocarditis confirmed on cardiac MRI.
Why the study?
Mesalamine-induced myocarditis diagnosis confirmed by cardiac MRI is rarely performed in published cases, highlighting a clinical diagnostic gap.
Case Report (n=1)
Cardiac MRI can be a useful tool to confirm the rare diagnosis of mesalamine-induced myocarditis, which resolves upon drug withdrawal and corticosteroid therapy.
Answers are grounded in this paper and cite their sources.
Cardiac MRI may aid diagnosis of rare mesalamine myocarditis; hypothesis-generating and should not yet change practice.
A 38-year-old Caucasian man with a medical history significant for inflammatory bowel disease (IBD) and mesalamine use presented to the emergency department with stabbing, pleuritic, substernal chest pain over the previous 2 days. Findings of leucocytosis, elevated cardiac enzymes and inflammatory markers, T-wave or ST-segment abnormalities and left ventricular systolic dysfunction suggested mesalamine-induced myocarditis. However, a cardiac MRI confirmed the diagnosis. Signs and symptoms improved within days of withdrawal of mesalamine, and initiation of corticosteroids and follow-up studies within the next year were unremarkable. Importantly, the diagnosis of mesalamine-induced myocarditis confirmed via cardiac MRI is a step rarely performed in published cases.
No takes yet. Share an insight, caveat, or question.
Baker et al. (2015) conducted a case report in Mesalamine-induced myocarditis (n=1). Mesalamine was evaluated on Clinical improvement. Cardiac MRI confirmed mesalamine-induced myocarditis in a 38-year-old man, whose symptoms improved within days of mesalamine withdrawal and corticosteroid initiation.
Synapse has enriched 10 related papers. Consider them for comparative context: